[Whitepaper] How Clinical Organizations Can Streamline Their Processes for the Digital Era
The COVID-19 pandemic has challenged the status quo and dramatically influenced the pharmaceutical and healthcare industry in many ways, particularly the clinical trial process. Although there was initially a slight dip in the number of trials conducted during the pandemic, it’s now clear that the number of clinical trials hasn’t declined but actually is rapidly increasing. The critical issue in the industry is not the threat of trials declining. Instead, it is the set of challenges facing contract research organizations (CROs) and other companies adapting to meet the needs of the “new normal” as the industry continues to go virtual. This white paper will discuss the current challenges facing the clinical trial process and discuss key strategies to solve these challenges.